‌

US Patent 9273064 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors

Patent 9273064 was granted and assigned to Leo Pharma on March, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Leo Pharma

Current Assignee

Leo Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

92730640

Patent Inventor Names

Simon Feldbaek Nielsen0

Date of Patent

March 1, 2016

Patent Application Number

145866810

Date Filed

December 30, 2014

Patent Citations Received

‌

US Patent 12084457 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

‌

US Patent 11981681 Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors

Patent Primary Examiner

‌

Wu-Cheng Winston Shen

Patent abstract

Compounds of the general formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9273064 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API